The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for KM Shokat


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIß.EBI
University of California
Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1.EBI
University of California
Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.EBI
Washington University
Features of selective kinase inhibitors.EBI
University of California San Francisco
A surface on the androgen receptor that allosterically regulates coactivator binding.EBI
University of California
Inhibitor hijacking of Akt activation.EBI
University of California
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics.EBI
University of California
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.EBI
Medical Research Council-Laboratory of Molecular Biology
Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2 subunits.EBI
University of California San Francisco
Structural bioinformatics-based design of selective, irreversible kinase inhibitors.EBI
University of California
Drugging the Next Undruggable KRAS Allele-Gly12Asp.EBI
University of California San Francisco
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.EBI
Qbi Covid-19 Research Group (Qcrg)
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.EBI
University of California
N-formylpyrazolines and N-benzoylpyrazolines as novel inhibitors of mammalian cathepsin B and cathepsin H.BDB
Kurukshetra University
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.BDB
Bristol-Myers Squibb
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.BDB
Vertex Pharmaceuticals
Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.BDB
Rheinische Friedrich-Wilhelms-Universitat Bonn